Sees FY26 revenue $480M-$500M, consensus $510.87M. Sees FY26 adjusted EBITDA $90M-$98M. Sees FY26 capital expenditures $20M. The company said, “As we look ahead, we believe our enhanced strategic clarity, decisive actions, and disciplined execution will position the company to deliver sustained growth off of our 2026 guidance expectations. Many of these actions are well underway, and they are already changing how we operate, giving us confidence that MGP will emerge better aligned, more resilient, and well positioned for long-term value creation.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGPI:
- MGPI Upcoming Earnings Report: What to Expect?
- Benchmark starts MGP Ingredients at Buy as company responds to challenges
- MGP Ingredients initiated with a Buy at Benchmark
- MGP Ingredients price target lowered to $24 from $27 at TD Cowen
- MGP Ingredients price target lowered to $29 from $33 at Wells Fargo